Diaceutics (LON:DXRX) Releases Quarterly Earnings Results

Posted by on May 28th, 2026

Diaceutics (LON:DXRX – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX 11 earnings per share for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 3,844 million for the quarter. Diaceutics had a negative net margin of 4.42% and a negative return on equity of 3.94%.

Diaceutics Trading Down 1.4%

Shares of Diaceutics stock opened at GBX 146 on Thursday. The firm has a market capitalization of £123.56 million, a PE ratio of -81.11 and a beta of 0.92. Diaceutics has a twelve month low of GBX 112.25 and a twelve month high of GBX 180. The firm’s 50-day moving average price is GBX 161.39 and its 200 day moving average price is GBX 154.34. The company has a current ratio of 3.96, a quick ratio of 9.92 and a debt-to-equity ratio of 3.05.

About Diaceutics

(Get Free Report)

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.

Featured Stories

Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.